Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GeneDx Holdings (WGS) Shares Outstanding (Weighted Average) (2020 - 2026)

GeneDx Holdings has reported Shares Outstanding (Weighted Average) over the past 7 years, most recently at $29.3 million for Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) rose 4.22% to $29.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $29.3 million through Mar 2026, up 4.22% year-over-year, with the annual reading at $28.6 million for FY2025, 6.51% up from the prior year.
  • Shares Outstanding (Weighted Average) was $29.3 million for Q1 2026 at GeneDx Holdings, up from $28.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $29.3 million in Q1 2026 and troughed at $7.4 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $26.1 million (2024), against an average of $22.3 million.
  • The largest YoY upside for Shares Outstanding (Weighted Average) was 1435.89% in 2022 against a maximum downside of 94.75% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $10.2 million in 2022, then soared by 137.49% to $24.3 million in 2023, then rose by 10.61% to $26.9 million in 2024, then rose by 6.51% to $28.6 million in 2025, then increased by 2.42% to $29.3 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Shares Outstanding (Weighted Average) are $29.3 million (Q1 2026), $28.6 million (Q4 2025), and $28.8 million (Q3 2025).